Glempa M 12.5mg/1000mg Tablet

Glempa M 12.5mg/1000mg Tablet is a combination medication containing two active ingredients: Empagliflozin & Metformin. Empagliflozin belongs to the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, while metformin is classified as a biguanide. This combination is prescribed for the management of type 2 diabetes mellitus.

Active Ingredients:

• Empagliflozin: Acts by inhibiting the reabsorption of glucose in the kidneys, leading to increased urinary excretion of glucose.
• Metformin: Works by reducing hepatic glucose production, decreasing intestinal absorption of glucose, and enhancing insulin sensitivity.

Uses:

Glempa M Tablet is indicated for the treatment of type 2 diabetes mellitus in adults. It helps control blood sugar levels through different mechanisms: empagliflozin promotes the excretion of glucose in the urine, while metformin reduces hepatic glucose production and improves insulin sensitivity.

Mechanism of Action:

• Empagliflozin: Inhibits sodium-glucose co-transporter 2 (SGLT2) in the kidneys, resulting in decreased glucose reabsorption and increased urinary glucose excretion.
• Metformin: Decreases hepatic glucose production, inhibits gluconeogenesis, reduces intestinal absorption of glucose, and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.

Administration:

Glempa M Tablet is typically taken orally with meals, as directed by a healthcare provider. The dosage may vary depending on individual response and other factors. Patients should adhere to the dosage instructions provided by their healthcare provider.

Side Effects:

Common side effects of Glempa M Tablet may include:

• Hypoglycemia (low blood sugar)
• Genital yeast infections
• Urinary tract infections
• Increased urination
• Thirst
• Nausea
• Diarrhea
• Abdominal pain

Precautions:

Before using Glempa M Tablet, patients should consider the following precautions:

• Inform healthcare providers of any known allergies to empagliflozin, metformin, or other medications.
• Regularly monitor blood sugar levels, especially during initial treatment or dosage adjustments.
• Use caution in patients with kidney problems, dehydration, or hypotension.
• Avoid excessive alcohol consumption, as it may increase the risk of lactic acidosis.
• Inform healthcare providers of any other medications, supplements, or herbal products being taken, as they may interact with empagliflozin or metformin.